Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy.
Nitecki Wilke R, Liu J, Westin SN, Fellman BM, Sims TT, Pham M, Rangel K, Sey E, Rauh-Hain JA, Lu KH, Sood AK, Fleming ND. Nitecki Wilke R, et al. Among authors: lu kh. Int J Gynecol Cancer. 2024 Oct 16:ijgc-2024-005893. doi: 10.1136/ijgc-2024-005893. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 39414313
Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries.
Bednar EM, Nitecki Wilke R, Jorgensen K, Walsh MT Jr, Nutt S, Lu KH, Nóbrega L, De Souza APSD, da Silva Oliveira G, da Cunha Andrade CEM, Purizaca-Rosillo N, Mora P, López Blanco A, Gallardo-Alvarado LN, Cantú-de León D, Rauh-Hain JA. Bednar EM, et al. Among authors: lu kh. J Community Genet. 2024 Dec;15(6):681-686. doi: 10.1007/s12687-024-00744-5. Epub 2024 Oct 14. J Community Genet. 2024. PMID: 39397225 Free PMC article.
Defining precancer: a grand challenge for the cancer community.
Faupel-Badger J, Kohaar I, Bahl M, Chan AT, Campbell JD, Ding L, De Marzo AM, Maitra A, Merrick DT, Hawk ET, Wistuba II, Ghobrial IM, Lippman SM, Lu KH, Lawler M, Kay NE, Tlsty TD, Rebbeck TR, Srivastava S; Precancer Think Tank Team. Faupel-Badger J, et al. Among authors: lu kh. Nat Rev Cancer. 2024 Nov;24(11):792-809. doi: 10.1038/s41568-024-00744-0. Epub 2024 Oct 1. Nat Rev Cancer. 2024. PMID: 39354069 Review.
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
How JA, Dang M, Lee S, Fellman B, Westin SN, Sood AK, Fleming ND, Shafer A, Yuan Y, Liu J, Zhao L, Celestino J, Hajek R, Morgan MB, Parra ER, Laberiano Fernandez CD, Arrechedera CA, Solis Soto LM, Schmeler KM, Nick A, Lu KH, Coleman R, Wang L, Jazaeri AA. How JA, et al. Among authors: lu kh. Med. 2024 Aug 15:100494. doi: 10.1016/j.medj.2024.07.022. Online ahead of print. Med. 2024. PMID: 39151421
795 results